ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation

Published:2020-03 Issue: Volume:123 Page:109750
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Wang Lei,Qi Yijun,Wang Xi,Li Lanxin,Ma Yuanzhen,Zheng Junfang

Funder

National Natural Science Foundation of the People’s Republic of China

Natural Science Foundation of Beijing

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference25 articles.

1. The SWI/SNF protein PBRM1 restrains VHL-loss-driven clear cell renal cell carcinoma;Nargund;Cell Rep.,2017

2. Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy;Voss;Clin. Cancer Res.,2014

3. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N. Engl. J. Med.,2007

4. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial;Motzer;Lancet,2008

5. Identification of six potentially long noncoding RNAs as biomarkers involved competitive endogenous RNA in clear cell renal cell carcinoma;Yang;Biomed Res. Int.,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy;Frontiers in Immunology;2024-09-12

2. Learning the Relationship Between Variants, Metabolic Fluxes and Phenotypes;2024-03-05

3. Targeting lipid biosynthesis on the basis of conventional treatments for clear cell renal cell carcinoma: A promising therapeutic approach;Life Sciences;2024-01

4. Expression and clinical significance of ECHS1 in gastric cancer;Journal of Cancer;2024

5. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration;Oncology Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3